半乳糖凝集素
半乳糖凝集素-3
半乳糖凝集素-1
化学
对接(动物)
血管生成
成纤维细胞
吲哚试验
纤维化
癌细胞
生物化学
癌症研究
癌症
生物
体外
医学
免疫学
内科学
护理部
遗传学
作者
Haoming Zhang,Xiaoyu Wang,Yong Wan,Li-Heng Liu,Jie Zhou,Ping Ping Li,Bailing Xu
标识
DOI:10.1021/acsmedchemlett.3c00261
摘要
Both galectin-3 and galectin-8 are involved in cell adhesion, migration, apoptosis, angiogenesis, and inflammatory processes by recognizing galactose-containing glycoproteins. Inhibiting galectin-3/8 activities is a potential treatment for cancer and tissue fibrosis. Herein, a series of novel N-arylsulfonyl-5-aryloxy-indole-2-carboxamide derivatives was disclosed as dual inhibitors toward galectin-3 and galectin-8 C-terminal domain with Kd values of low micromolar level (Cpd53, gal-3: Kd = 4.12 μM, gal-8C: Kd = 6.04 μM; Cpd57, gal-3: Kd = 12.8 μM, gal-8C: Kd = 2.06 μM), which are the most potent and selective noncarbohydrate-based inhibitors toward gal-3/8 isoforms to date. The molecular docking investigations suggested that the unique amino acids Arg144 in galectin-3 and Ser213 in galectin-8C could contribute to their potency and selectivity. The scratch wound assay demonstrated that Cpd53 and Cpd57 were able to inhibit the MRC-5 lung fibroblast cells migration as well. This class of inhibitors could serve as a new starting point for further discovering structurally distinct gal-3 and gal-8C inhibitors to be used in cancer and tissue fibrosis treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI